Work Description - Open Tender Enquiry For Rate Contract For Immunohistochemistry Consumables Including Antibodies Compatible For Working On Roche Benchmark Xt (ventana Platform)

The Delhi State Cancer Institute (DSCI) is inviting bids for an open tender to establish a rate contract for the supply of Immunohistochemistry consumables, including antibodies compatible with the Roche Benchmark XT (Ventana platform). This tender, identified as DSCI-D011(14)/1/2024-Purchase (DSCI), is open to all eligible suppliers. The tender documents can be downloaded starting September 13th, 2024, and the deadline for submission is October 4th, 2024, at 1:30 PM. A pre-bid meeting is scheduled for September 17th, 2024, at 12:00 PM at the Delhi State Cancer Institute. Bidders must submit a bid security of ₹25,000 in the form of a Demand Draft payable to the Director, Delhi State Cancer Institute. The tender requires three separate covers: one for the bid security, another for prequalification and technical documents, and the final cover for the Bill of Quantities (BOQ). The DSCI reserves the right to accept or reject any or all bids without assigning any reason.